PT  - JOURNAL ARTICLE
AU  - Pérez Gaxiola, Giordano
AU  - Rocha, Rosalino Flores
AU  - Valadez Vidarte, Julio César
AU  - Alcaraz, Melissa Hernández
AU  - Mendoza, Gilberto Herrera
AU  - Del Real Lugo, Miguel Alejandro
TI  - Clinical and epidemiological characteristics of children with SARS-CoV-2 infection: case series in Sinaloa
AID  - 10.1101/2020.07.07.20146332
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.07.20146332
4099  - http://medrxiv.org/content/early/2020/07/11/2020.07.07.20146332.short
4100  - http://medrxiv.org/content/early/2020/07/11/2020.07.07.20146332.full
AB  - Background The SARS-CoV-2 virus may affect both adults and children. Although the disease, named COVID-19, has a lower prevalence in infancy and has been described as mild, the clinical characteristics may vary and there is a possibility of complications.Objectives To describe the clinical and epidemiological characteristics of pediatric cases confirmed in the state of Sinaloa, Mexico, during the first three months of the pandemic, and of children admitted with COVID-19 to a secondary hospital.Methods This case series includes all patients with SARS-CoV-2 infection confirmed by PCR testing, identified in the state epidemiological surveillance system between March 1 and May 31, 2020. Confirmed patients admitted to the Sinaloa Pediatric Hospital (HPS) during the same dates are also described.Results Fifty one children with SARS-CoV-2 were included, 10 of the admitted to HPS. The median age was 10 years. The more frequent symptoms were fever (78%), cough (67%) and headache (57%). Most cases were mild or asymptomatic. Three patients with comorbidities died. Only 4 of 10 patients identified in HPS had been admitted with the diagnosis of possible COVID-19.Conclusions SARS-CoV-2 infection in children was mostly mild or asymptomatic, but with a wide range of clinical presentations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDid not receive funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approved by IRB of Sinaloa Pediatric Hospital.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAvailable per request.